Women stopped using bisphosphonates for more than two years showed a significantly higher risk of a hip fracture when compared to other women who continued taking the osteoporosis medication, according to new research. The findings were presented at the 2017 meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP). Osteoporosis is a… Continue reading Should You Stop Taking Your Osteoporosis Medication?
Tag: bisphosphonates
Some Osteoporosis Medicines May Not Be Beneficial Over the Long Term
Women who took bisphosphonates for up to 13 years in an effort to combat osteoporosis had no fewer fractures than women who took the medicines only briefly, research shows. Osteoporosis causes thinning of the bones, loss of bone density, and increasingly fragile bones. This puts people at higher risk for bone fractures. Risk for the… Continue reading Some Osteoporosis Medicines May Not Be Beneficial Over the Long Term
New Guidelines for Treating Osteoporosis
A physicians’ group has recommended new guidelines that doctors treat women who have osteoporosis with bisphosphonates (alendronate, risedronate, or zoledronic acid) or denosumab, a biologic agent. The new guidelines, from the American College of Physicians (ACP), were published in the Annals of Internal Medicine, according to a news release from the ACP. ACP’s previous recommendations… Continue reading New Guidelines for Treating Osteoporosis